Skip to main content

Table 1 Laboratory data during DCV/ASV therapy

From: Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report

Data

Normal range

Weeks

 

0

4

10

14

18

22

24

Creatinine

(0.4–0.7)

1.83

1.51

1.33

1.07

1.18

1.1

1.06

eGFR (mL/min/1.73 m2)

 

25.9

27.2

31.1

39.5

35.5

35.5

38.3

C3 (mg/dl)

(35–65)

56

86

87

96

95

99

94

C4 (mg/dl)

(13–35)

1

4

3

4

3

3

3

CH50 (U/mL)

(23–46)

10

17.2

17.4

39.6

31.9

32.7

29.1

Proteinuria (g/g・cre)

(<0.15)

1.94

0.62

0.16

1.38

0.65

0.93

0.13

Hematuria(/HPF)

(<5)

50

10.8

5.3

15.3

10.8

12.2

3.9

Cryoglobulin

(−)

+

 

+

 

+

 

+

GOT (U/L)

(13–33)

32

27

25

24

24

27

24

GPT (U/L)

(6–27)

32

23

23

22

21

19

20

γ-GTP (U/L)

(10–47)

63

51

32

26

24

24

22

  1. Abbreviations: eGFR estimated glomerular filtration rate, HPF high power field, GOT glutamate oxaloacetate transaminase, GPT glutamate pyruvate transaminase, γ-GTP γ-glutamyl trans peptidase